Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
2018.12.11
Active substance: dienogest, ethinylestradiol
The company Jenapharm GmbH & Co. KG provides information on the risk of venous thromboembolism (VTE) in women using contraceptives containing dienogest and ethinylestradiol compared to women using levonorgestrel and ethinylestradiol combinations, which are associated with a lower risk.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN